symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
MYNZ,2.31,0,123390,38686725,0,2.15-9.614,0.09,Mainz Biomed B.V.,USD,0001874252,NL0015000LC2,N5436L101,NASDAQ Capital Market,NASDAQ,Diagnostics & Research,https://mainzbiomed.com,"Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.",Mr. Guido  Baechler,Healthcare,DE,58,49 6131 554 2860,Robert Koch Strasse 50,Mainz,,55129,,0,https://financialmodelingprep.com/image-stock/MYNZ.png,2021-11-05,False,False,True,False,False
